These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


368 related items for PubMed ID: 2613151

  • 21. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention.
    Mulcahey MK, Schiller JR, Hulstyn MJ.
    Phys Sportsmed; 2010 Oct; 38(3):105-13. PubMed ID: 20959703
    [Abstract] [Full Text] [Related]

  • 22. Drug testing in elite athletes--the Israeli perspective.
    Epstein S, Eliakim A.
    Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300
    [Abstract] [Full Text] [Related]

  • 23. [Point of view on doping].
    Naeije R, Pagnamenta A.
    Rev Med Brux; 1999 Jun; 20(3):153-8. PubMed ID: 10429539
    [Abstract] [Full Text] [Related]

  • 24. [Doping control in race horses].
    Ungemach FR.
    Tierarztl Prax; 1985 Jun; 13(1):35-53. PubMed ID: 2859671
    [Abstract] [Full Text] [Related]

  • 25. Detection of androgenic anabolic steroids in urine.
    Hatton CK, Catlin DH.
    Clin Lab Med; 1987 Sep; 7(3):655-68. PubMed ID: 3308301
    [Abstract] [Full Text] [Related]

  • 26. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM, Congeni JA.
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [Abstract] [Full Text] [Related]

  • 27. Hormone abuse in sports: the antidoping perspective.
    Barroso O, Mazzoni I, Rabin O.
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [Abstract] [Full Text] [Related]

  • 28. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M, Schänzer W.
    Mass Spectrom Rev; 2007 May; 26(1):79-107. PubMed ID: 16888758
    [Abstract] [Full Text] [Related]

  • 29. [Anabolics and sports].
    Horber FF.
    Schweiz Med Wochenschr; 1990 Mar 17; 120(11):383-7. PubMed ID: 2320982
    [Abstract] [Full Text] [Related]

  • 30. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA, Grace F, Smith JC, Morris K, Cockcroft J, Scanlon MF, Davies JS.
    Eur J Clin Invest; 2006 Jul 17; 36(7):483-8. PubMed ID: 16796605
    [Abstract] [Full Text] [Related]

  • 31. [General practitioners and doping in sports: knowledge and attitudes].
    Laure P.
    Sante Publique; 1997 Jun 17; 9(2):145-56. PubMed ID: 9417372
    [Abstract] [Full Text] [Related]

  • 32. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-Goedkoop NM, Pigozzi F, Schänzer W, Vanhees L, ESC Study Group of Sports Cardiology.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct 17; 13(5):687-94. PubMed ID: 17001206
    [Abstract] [Full Text] [Related]

  • 33. Anabolic steroids in athletics.
    Holden SC, Calvo RD, Sterling JC.
    Tex Med; 1990 Mar 17; 86(3):32-6. PubMed ID: 2333633
    [Abstract] [Full Text] [Related]

  • 34. Endogenous steroid profiling in the athlete biological passport.
    Sottas PE, Saugy M, Saudan C.
    Endocrinol Metab Clin North Am; 2010 Mar 17; 39(1):59-73, viii-ix. PubMed ID: 20122450
    [Abstract] [Full Text] [Related]

  • 35. [Medication, athletes and doping regulations].
    Hartgens F.
    Ned Tijdschr Geneeskd; 2008 Aug 16; 152(33):1844-8. PubMed ID: 18783164
    [Abstract] [Full Text] [Related]

  • 36. [Anabolic steroids and their abuse in sports].
    Bruno M.
    Clin Ter; 1990 Nov 15; 135(3):159-72. PubMed ID: 2150017
    [Abstract] [Full Text] [Related]

  • 37. Illicit drugs and cardiac arrhythmias in athletes.
    Furlanello F, Serdoz LV, Cappato R, De Ambroggi L.
    Eur J Cardiovasc Prev Rehabil; 2007 Aug 15; 14(4):487-94. PubMed ID: 17667636
    [Abstract] [Full Text] [Related]

  • 38. Steroid analysis and doping control 1960-1980: scientific developments and personal anecdotes.
    Shackleton C.
    Steroids; 2009 Mar 15; 74(3):288-95. PubMed ID: 19013476
    [Abstract] [Full Text] [Related]

  • 39. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H, Simon P, Frisch S, Roecker K, Dietz K, Dickhuth HH, Ulrich R.
    Drug Alcohol Depend; 2006 Jan 04; 81(1):11-9. PubMed ID: 16009506
    [Abstract] [Full Text] [Related]

  • 40. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
    Van Eenoo P, Delbeke FT.
    J Steroid Biochem Mol Biol; 2006 Nov 04; 101(4-5):161-78. PubMed ID: 17000101
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.